A recent review discusses the emerging nanomedications and therapies with potential to alter Duchenne’s fatal outcome.

A recent review discusses the emerging nanomedications and therapies with potential to alter Duchenne’s fatal outcome.
Extracellular vesicles are highly biocompatible and efficient carriers for targeted and personalized drug delivery.
Researchers demonstrated a new approach to fabricate large-scale, complex nano-architectures of refractory plasmonic transition metal nitrides.
March’s top Advanced Healthcare Materials papers
A new hybrid nanomaterial combines membranes from multiple cell types, enabling the fabrication of membrane-coated nanoparticles with an increased number of functionalities.
A diverse range of nanomaterials with different physicochemical characteristics have been developed to stimulate the immune system and battle cancer.
Taking the headache out of brain surgery: these gold nanoparticles cross the blood–brain barrier and report when they hit tumour tissue.
Antitumour platform comes of age: this system gets the responsible drug to keep itself in check for transport and delivery.
March’s Advanced Healthcare Materials covers
The application and the clinical development of nanomedicines strongly requires a deep study on the complex dynamics that happen after in vivo administration. Particularly, plasma proteins tend to associate to nanoparticles, forming a new surface named the “protein corona” that can have a strong impact on biodistribution, targeting efficacy, and toxicity.